{
"NDC": {
"NDCCode": "17856-0722-4",
"PackageDescription": "44 POUCH in 1 BOX, UNIT-DOSE (17856-0722-4) / 1 LOZENGE in 1 POUCH",
"NDC11Code": "17856-0722-04",
"ProductNDC": "17856-0722",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Nicotine",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Nicotine Polacrilex Mini",
"DosageFormName": "LOZENGE",
"RouteName": "ORAL",
"StartMarketingDate": "20221103",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA215357",
"LabelerName": "Atlantic Biologicals Corp",
"SubstanceName": "NICOTINE",
"StrengthNumber": "2",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-10-12",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20261005",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}